Navigation Links
Sangamo BioSciences Reports Third Quarter 2008 Financial Results
Date:10/29/2008

September 30, September 30,

2008 2007 2008 2007

Consolidated Statement of Operations

Data:

Revenues:

Collaboration agreements $3,196 $1,915 $7,658 $4,526

Research grants 549 410 1,694 1,805

Total revenues 3,745 2,325 9,352 6,331

Operating expenses:

Research and development 7,563 5,916 24,492 17,655

General and administrative 2,564 1,728 8,036 5,840

Total operating expenses 10,127 7,644 32,528 23,495

Loss from operations (6,382) (5,319) (23,176) (17,164)

Interest income, net 42 1,051 1,448 2,356

Net loss $(6,340) $(4,268) $(21,728) $(14,808)

Basic and diluted net loss per

common share $(0.15) $(0.11) $(0.53) $(0.41)

Shares used in computing basic and

diluted net loss per common share 40,928 38,925 40,759 36,387

CONDENSED BALANCE SHEET DATA

September 30, 2008 December 31, 2007

Cash, cash equivalents, and investments $59,458 $81,412

Total assets 70,749 83,900

Total stockholders' equity 56,021 72,122


'/>"/>
SOURCE Sangamo BioSciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Sangamo BioSciences Presents Data at ICAAC Demonstrating In Vivo Protection Against HIV Infection by CCR5-ZFN Therapeutic
2. Sangamo BioSciences Announces Third Quarter Conference Call and Webcast
3. Sangamo BioSciences to Present at Two Upcoming Investor Conferences
4. Sangamo BioSciences to Present at the UBS Global Life Sciences Conference
5. Sangamo BioSciences to Present at the Canaccord Adams Global Growth Conference
6. Sangamo BioSciences to Present at the BMO Capital Markets Focus on Healthcare Conference
7. Sangamo BioSciences Reports Second Quarter 2008 Financial Results
8. Sangamo BioSciences Announces Second Quarter Conference Call and Webcast
9. Sangamo BioSciences and Sigma-Aldrich Announce Research and License Agreement With Roche for the Use of ZFN Technology for Generation of Transgenic Animals
10. Dow AgroSciences Announces Early Exercise of Option for Commercial License With Sangamo BioSciences for Plants
11. Dow AgroSciences, Sangamo BioSciences Announce the Achievement of Key Milestones in Plant Agriculture Collaboration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)...  Quest Diagnostics Incorporated (NYSE: DGX ), the ... it is scheduled to speak at the Jefferies 2015 ... , the company,s President and CEO, will discuss the ... is scheduled for Tuesday, June 2, 2015 at 8:00 ... webcast live during the conference and will be available ...
(Date:5/28/2015)... , May 27, 2015 Research and Markets( ... "Animal Genetics Market by Products, by Testing services - ... The global animal genetics market is estimated ... grow at a CAGR of 8-9% during the forecast ... is mainly driven by increasing animal protein consumption, increasing ...
(Date:5/28/2015)... The Academy of Model Aeronautics Foundation will be celebrating ... 2015. National Model Aviation Day was created to celebrate the ... to the general public. , The AMA has encouraged all ... celebration by hosting events in their own communities. More than ... events. View our online event map to find an ...
(Date:5/28/2015)... May 28, 2015 DryLet, LLC ... in applications such as animal waste reduction, bioremediation, ... reduction in wastewater treatment plants and restaurant kitchen ... World Pork Expo, June 3-5 in Des Moines, ... in a Wall Street Journal article because of ...
Breaking Biology Technology:Quest Diagnostics to Speak at the Jefferies 2015 Global Healthcare Conference 2Global Animal Genetics (Canine, Equine, Poultry, Porcine, Bovine, and Genetic Material) Market 2015 - Global Forecast to 2020 2Model flying pilots celebrate the Academy of Model Aeronautics Foundation’s Third Annual National Model Aviation Day 2DryLet to Showcase Patented ManureMagic™ at the 2015 World Pork Expo, June 3-5 in Des Moines, Iowa 2
... InterMune, Inc.,(Nasdaq: ITMN ) today announced results from operations ... company also provided 2008,financial guidance and milestones for its key ... InterMune reported a net loss for the fourth quarter of ... net loss of $21.5 million, or,$0.64 per share, in the ...
... prices,devaluing dollar, soaring gas prices, and the slumping real ... the recession hitting the U.S. economy.,While a recession will ... pharma and biotech companies as they have already been ... of newly,approved therapies. Given the current environment, it is ...
... DCGN ) today announced that it will host ... presentation at Biotechnology,Industry Organization (BIO) CEO and Investor Conference., ... ET / 19:45GMT on Monday,February 11 at the Waldorf-Astoria ... the Investors page on deCODE,s website, http://www.decode.com, and ...
Cached Biology Technology:InterMune Announces Fourth Quarter and Full Year 2007 Financial Results and Provides 2008 Guidance 2InterMune Announces Fourth Quarter and Full Year 2007 Financial Results and Provides 2008 Guidance 3InterMune Announces Fourth Quarter and Full Year 2007 Financial Results and Provides 2008 Guidance 4InterMune Announces Fourth Quarter and Full Year 2007 Financial Results and Provides 2008 Guidance 5InterMune Announces Fourth Quarter and Full Year 2007 Financial Results and Provides 2008 Guidance 6InterMune Announces Fourth Quarter and Full Year 2007 Financial Results and Provides 2008 Guidance 7InterMune Announces Fourth Quarter and Full Year 2007 Financial Results and Provides 2008 Guidance 8InterMune Announces Fourth Quarter and Full Year 2007 Financial Results and Provides 2008 Guidance 9InterMune Announces Fourth Quarter and Full Year 2007 Financial Results and Provides 2008 Guidance 10InterMune Announces Fourth Quarter and Full Year 2007 Financial Results and Provides 2008 Guidance 11Pharmaceutical Budget and Staffing: Powerful New Metrics-Based Study 2
(Date:5/11/2015)... May 11, 2015 Curemark LLC, a privately ... of a new Phase III double blind, randomized, placebo-controlled ... formulation, CM-AT, on all children ages 3-8 with Autism. ... Phase III double blinded clinical trial for CM-AT in ... of the digestive enzyme chymotrypsin. This new trial will ...
(Date:5/6/2015)... 2015 LifeBEAM, a developer of bio-sensing technology, ... today that they will expand their partnership in bio-sensing ... cycling helmet and the first joint project between the ... in order to give cyclists more style choices and ... and Lazer announced their plan to release a new ...
(Date:4/27/2015)... LAUDERDALE, Fla. , Apr. 27, 2015 ... of access control and security systems is pleased to ... the company as a consultant and member of its ... is widely known as a thought leader in ... Distance Learning Technology Group, and has published studies and ...
Breaking Biology News(10 mins):Curemark, LLC, Launches New Phase III Trial in Expanded Population of Children with Autism 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 3Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 2Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 3Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 4
... & Children,s Hospital and the University of Adelaide, Australia, ... with high blood pressure during pregnancy and pre-term birth. ... of Obstetrics & Gynaecology, are a major step forward ... blood pressure in pregnancy. The research has been ...
... balance of nature looms prominently in the public mind these ... declining fish stocks are but a few of the issues ... is it? It depends on whom you ask, ... the School of Life Sciences specializing in biology and society. ...
... no group takes credit. The pressure on the U.S. ... the president orders an attack, but it turns out ... Things go downhill from there. , To avoid that ... with extensive nuclear expertise, headed by Stanford physicist Michael ...
Cached Biology News:Herpes virus link to complications in pregnancy 2Managing uncertainty important in ecological balance: ASU researcher 2Group led by Stanford physicist says there's an urgent need for nuclear detectives 2Group led by Stanford physicist says there's an urgent need for nuclear detectives 3
Anti-ADAMTS-4, disintegrin-like domain Immunogen: Synthetic peptide - KLH conjugated Available Date: 38569...
Rat integrin a6b1, mainly associated with epithelial cells. Does not react with rat fibroblasts....
Rabbit polyclonal to Streptococcus Enterotoxin C ( Abpromise for all tested applications)....
Mouse monoclonal [4i144] to HLA Class II DQ1 7 ( Abpromise for all tested applications). Antigen: Full length protein (Human): HLA Class 2 Antigen DQ1,7....
Biology Products: